查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790271

美國伴侶動物感染疾病診斷市場規模、佔有率和趨勢分析報告（按動物類型、感染類型、產品、技術、最終用途和細分市場預測，2025 年至 2033 年）

U.S. Companion Animal Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Infection Type (Bacterial, Viral, Parasitic), By Product, By Technology, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美國伴侶動物感染疾病診斷市場概況

美國伴侶動物感染疾病診斷市場規模預計在 2024 年為 3.806 億美元，預計到 2033 年將達到 6.353 億美元，2025 年至 2033 年的複合年成長率為 6.02%。市場成長受到感染疾病病率上升、先進技術融合度提高、伴侶動物診斷設備監管批准增加以及該國官民合作關係不斷加強等因素的推動。

美國伴侶動物診斷領域正透過先進技術與綜合研究模式的結合，快速加速創新。獸醫診斷領域的頂尖專家強調，人工智慧 (AI) 在從血液和尿液檢查到影像平台和醫療記錄系統等各個領域的變革中發揮著日益重要的作用。

像 Zoetis 的 Vetscan OptiCell 和 Imagyst 這樣的人工智慧分析儀，能夠在常規診療流程中更快、更準確地識別血球異常和病理變化。這些系統減少了變異性，減輕了獸醫人員的工作量，同時為診斷決策提供即時支援。在診斷影像領域，經過數百萬張 X 光和超音波影像訓練的機器學習模型可以檢測出貓狗掃描影像中的細微模式，提供接近人類的專業診斷效能和更快的周轉時間。將人工智慧整合到記錄保存、排程、自動化 SOAP 記錄和趨勢分析工具中，還可以簡化診療管理，提高一致性，並使獸醫能夠專注於患者照護和客戶溝通。

同時，「同一個健康」研究舉措，例如 2025 年 5 月德克薩斯A&M 大學和喬治亞大學關於犬南美錐蟲病的合作研究，正在透過在動物/人類健康綜合框架內解決通用感染疾病來重塑診斷重點。在最近超過 400 萬美元的資助下，這些研發工作正在開發高靈敏度的診斷面板（基於 DNA 和血清學生物標記）、分期通訊協定和改進的治療方法，以管理美國南部高風險犬群中的克氏錐蟲感染疾病。透過監測私人寵物和工作犬，研究人員正在收集臨床和生態學數據，以了解疾病進展、心臟影響和暴露途徑，直接指導改進的診斷和早期療育策略。 「同一個健康」方法確保犬隻診斷和治療通訊協定的進步直接轉化為流行地區的人類健康應用。

推動伴隨診斷成長的其他趨勢包括寵物照護日益複雜（寵物老化、合併症）、獸醫部門的人力限制以及對快速可靠診斷結果日益成長的需求。互聯互通和遠端醫療工具使診所能夠利用雲端基礎的人工智慧平台、遠端解釋服務和決策支援系統，從而更有效率地做出更明智的臨床決策。

總而言之，這些發展，例如能夠提高速度和準確性的人工智慧診斷技術，加上一體化健康研發，正在推動伴侶動物診斷產業的發展。這些技術使獸醫能夠更早發現疾病，制定個人化治療通訊協定，最佳化診所營運，並使動物健康工作與更廣泛的公共衛生目標保持一致。血液分析儀、影像人工智慧和疾病診斷流程等創新體現了跨科學、臨床實踐和各領域部門的合作如何推動美國精準獸醫醫學的新時代。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國伴侶動物感染疾病診斷市場的趨勢與展望

  • 市場體系展望
    • 母市場
    • 子公司市場
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國伴侶動物感染疾病診斷市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析
    • 法律規範
    • 定價分析
    • 疾病流行分析
    • 以主要國家和物種估計的動物數量（2024 年）

第4章美國伴侶動物感染疾病診斷市場（依動物類型、估計和趨勢分析）

  • 細分儀表板
  • 美國伴侶動物感染疾病診斷市場：動物類型變異分析
  • 美國伴侶動物感染疾病診斷市場規模及趨勢分析（依動物類型），2021-2033
  • 狗
  • 貓
  • 馬
  • 其他

第5章美國伴侶動物感染疾病診斷市場技術、預測與趨勢分析

  • 細分儀表板
  • 美國伴侶動物感染疾病診斷市場：技術變革分析
  • 美國伴侶動物感染疾病診斷市場規模及趨勢分析（依技術分類）（2021-2033）
  • 免疫診斷
    • 橫向流動化驗
    • ELISA檢測
    • 其他
  • 分子診斷
    • 聚合酵素鏈鎖反應（PCR）檢測
    • 微陣列
    • 其他
  • 其他

第6章美國伴侶動物感染疾病診斷市場（依產品、估計和趨勢分析）

  • 細分儀表板
  • 美國伴侶動物感染疾病診斷市場：產品差異分析
  • 2021-2033 年美國伴侶動物感染疾病診斷市場規模及趨勢分析（依產品）
    • 耗材、試劑和套件
    • 設備和儀器

第7章美國伴侶動物感染疾病診斷市場：依感染疾病類型進行的估計與趨勢分析

  • 細分儀表板
  • 美國伴侶動物感染疾病診斷市場：感染疾病類型波動分析
  • 美國伴侶動物感染疾病診斷市場規模及趨勢分析（依感染疾病類型，2021-2033）
    • 細菌
    • 病毒
    • 寄生蟲
    • 其他

第8章美國伴侶動物感染疾病診斷市場最終用途、預測與趨勢分析

  • 細分儀表板
  • 美國伴侶動物感染疾病診斷市場：最終用途變異分析
  • 美國伴侶動物感染疾病診斷市場規模及趨勢分析（依最終用途），2021-2033
    • 獸醫醫院和診所
    • 獸醫參考實驗室
    • 其他

第9章 競爭態勢

  • 市場參與企業分類
  • 企業市場分析/熱圖分析
  • 公司簡介
    • IDEXX Laboratories Inc.
    • Zoetis Services LLC.
    • Antech Diagnostics, Inc.
    • Thermo Fisher Scientific, Inc
    • Virbac
    • bioMerieux SA
    • Neogen Corporation
    • IDVet
    • Agrolabo SpA
    • Bio-Rad Laboratories, Inc
  • 戰略地圖
    • 合併與收購
    • 夥伴關係和合作
    • 產品發布
    • 其他
  • 其他主要角色列表
Product Code: GVR-4-68040-678-2

U.S. Companion Animal Infectious Disease Diagnostics Market Summary

The U.S. companion animal infectious disease diagnostics market size was estimated at USD 380.6 million in 2024 and is projected to reach USD 635.3 million by 2033, growing at a CAGR of 6.02% from 2025 to 2033. The market growth is fueled by factors such as the rising incidence of infectious diseases, the growing integration of advanced technologies, increasing regulatory approvals for companion animal diagnostic devices, and expanding public-private partnerships in the country.

In the U.S. companion animal diagnostics space, innovation is rapidly accelerating by combining advanced technologies and integrative research models. Leading experts in veterinary diagnostics emphasize that artificial intelligence (AI) plays an increasingly central role in transforming everything from bloodwork and urinalysis to imaging platforms and medical record systems.

AI powered analyzers such as Zoetis's Vetscan OptiCell and Imagyst enable faster, more accurate identification of blood cell abnormalities and pathological changes during routine clinic workflows. These systems reduce variability and lighten the workload on veterinary staff while delivering real time support for diagnostic decisions. In imaging, machine learning models trained on millions of x ray and ultrasound images can detect subtle patterns in canine and feline scans, offering near-human-expert diagnostic performance and much quicker turnaround times. AI integration into record keeping, scheduling, SOAP note automation, and trend analysis tools is also streamlining practice management, improving consistency, and freeing veterinarians to focus on patient care and client communication.

At the same time, One Health research initiatives, such as the May 2025 collaboration between Texas A&M and the University of Georgia on Chagas disease in dogs, are reshaping diagnostic priorities by tackling zoonotic infections within a combined animal/human health frame. Backed by over USD 4 million in recent funding, these researchers are developing sensitive diagnostic panels (DNA based and serologic biomarkers), staging protocols, and modified therapeutic regimens to manage Trypanosoma cruzi infection in canine cohorts at high risk in southern U.S. settings. By monitoring privately owned pets and working dogs, researchers are gathering clinical and ecological data to capture disease progression, cardiac impact, and exposure routes, feeding directly into improved diagnostics and early intervention strategies. The One Health approach ensures that advances in canine diagnostics and treatment protocols can directly inform human health applications in endemic regions.

Other converging trends fueling growth in companion diagnostics include the increasing complexity of pet care (pet aging, comorbidities), workforce constraints in the veterinary sector, and rising demand for rapid and trustworthy diagnostic results. With connectivity and telemedicine tools, clinics can leverage cloud based AI platforms, remote interpretation services, and decision support systems to make smarter clinical choices more efficiently.

To conclude, these developments, like AI enabled diagnostic technologies delivering heightened speed and accuracy, combined with integrative One Health research collaborations, are propelling the companion animal diagnostics industry forward. They enable veterinarians to detect disease earlier, personalize treatment protocols, optimize clinic operations, and align animal health efforts with broader public health goals. Innovations such as hematology analyzers, imaging AI, and disease diagnostic pipelines exemplify how science, clinical practice, and cross disciplinary collaboration drive a new era of precision veterinary medicine in the U.S.

U.S. Companion Animal Infectious Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. companion animal infectious disease diagnostics market report based on animal type, product, technology, Infection type, and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Consumables, Reagents & Kits
  • Equipment & Instruments
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunodiagnostics
    • Lateral Flow Assays
    • ELISA Test
    • Others
  • Molecular Diagnostic
    • Polymerase Chain Reaction (PCR) Tests
    • Microarrays
    • Others
  • Others
  • Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Canine
  • Feline
  • Equine
  • Others
  • Infection Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Bacterial
  • Viral
  • Parasitic
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals and Clinics
  • Veterinary Reference Laboratories
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Country Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Companion Animal Infectious Disease Diagnostics Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Incidence Of Infectious Diseases
      • 3.2.1.2. Growing Integration Of Advanced Technologies
      • 3.2.1.3. Increasing Regulatory Approvals For Companion Animal Diagnostic Devices
      • 3.2.1.4. Expanding Public-Private Partnerships In The Country
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of standardized regulations
      • 3.2.2.2. Lack of awareness in developing economies
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. U.S. Companion Animal Infectious Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Pricing Analysis
    • 3.3.5. Disease Prevalence Analysis
    • 3.3.6. Estimated Animal Population by key countries, key species, 2024

Chapter 4. U.S. Companion Animal Infectious Disease Diagnostics Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Companion Animal Infectious Disease Diagnostics Market: Animal Type Movement Analysis
  • 4.3. U.S. Companion Animal Infectious Disease Diagnostics Market Size & Trend Analysis, by animal type, 2021 to 2033 (USD Million)
  • 4.4. Canine
    • 4.4.1. Canine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Feline
    • 4.5.1. Feline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Equine
    • 4.6.1. Equine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Companion Animal Infectious Disease Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Companion Animal Infectious Disease Diagnostics Market: Technology Movement Analysis
  • 5.3. U.S. Companion Animal Infectious Disease Diagnostics Market Size & Trend Analysis, by technology, 2021 to 2033 (USD Million)
  • 5.4. Immunodiagnostics
    • 5.4.1. Immunodiagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Lateral Flow Assays
      • 5.4.2.1. Lateral Flow Assays Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. ELISA Test
      • 5.4.3.1. ELISA Test Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Molecular Diagnostic
    • 5.5.1. Molecular Diagnostic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Polymerase Chain Reaction (PCR) Tests
      • 5.5.2.1. Polymerase Chain Reaction (PCR) Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Microarrays
      • 5.5.3.1. Microarrays Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Companion Animal Infectious Disease Diagnostics Market: By Product Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Companion Animal Infectious Disease Diagnostics Market: By Product Movement Analysis
  • 6.3. U.S. Companion Animal Infectious Disease Diagnostics Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
    • 6.3.1. Consumables, Reagents & Kits
      • 6.3.1.1. Consumables, Reagents & Kits Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Equipment & Instruments
      • 6.3.2.1. Equipment & Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Companion Animal Infectious Disease Diagnostics Market: By Infection Type, Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Companion Animal Infectious Disease Diagnostics Market: By Infection Type Movement Analysis
  • 7.3. U.S. Companion Animal Infectious Disease Diagnostics Market Size & Trend Analysis, by Infection type, 2021 to 2033 (USD Million)
    • 7.3.1. Bacterial
      • 7.3.1.1. Bacterial Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Viral
      • 7.3.2.1. Viral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Parasitic
      • 7.3.3.1. Parasitic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Others
      • 7.3.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Companion Animal Infectious Disease Diagnostics Market: By End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Companion Animal Infectious Disease Diagnostics Market: By End Use Movement Analysis
  • 8.3. U.S. Companion Animal Infectious Disease Diagnostics Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
    • 8.3.1. Veterinary Hospitals and Clinics
      • 8.3.1.1. Veterinary Hospitals and Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. Veterinary Reference Laboratories
      • 8.3.2.1. Veterinary Reference Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Others
      • 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heat Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. IDEXX Laboratories Inc.
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Zoetis Services LLC.
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Antech Diagnostics, Inc.
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Thermo Fisher Scientific, Inc
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Virbac
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. bioMerieux SA
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Neogen Corporation
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. IDVet
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Agrolabo S.p.A.
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Bio-Rad Laboratories, Inc
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
  • 9.4. Strategy Mapping
    • 9.4.1. Mergers & Acquisitions
    • 9.4.2. Partnerships & Collaborations
    • 9.4.3. Product launch
    • 9.4.4. Others
  • 9.5. List of other key players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 U.S. Companion animal infectious disease diagnostics Market, by Animal type, 2021 - 2033 (USD Million)
  • Table 3 U.S. Companion animal infectious disease diagnostics Market, by Infection Type, 2021 - 2033 (USD Million)
  • Table 4 U.S. Companion animal infectious disease diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 5 U.S. Companion animal infectious disease diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 6 U.S. Companion animal infectious disease diagnostics Market, by End use, 2021 - 2033 (USD Million)
  • Table 7 Company Overview
  • Table 8 Product Benchmarking
  • Table 9 Financial Performance
  • Table 10 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Companion animal infectious disease diagnostics Market revenue, 2021 - 2033 (USD Million)
  • Fig. 10 U.S. Companion animal infectious disease diagnostics Market snapshot
  • Fig. 11 U.S. Companion animal infectious disease diagnostics Market driver impact
  • Fig. 12 U.S. Companion animal infectious disease diagnostics Market restraint impact
  • Fig. 13 U.S. Companion animal infectious disease diagnostics animal type key takeaways (USD Million)
  • Fig. 14 U.S. Companion animal infectious disease diagnostics Market: animal Type movement analysis
  • Fig. 15 Canine market, 2021 - 2033 (USD Million)
  • Fig. 16 Feline market, 2021 - 2033 (USD Million)
  • Fig. 17 Equine market, 2021 - 2033 (USD Million)
  • Fig. 18 Others market, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Companion animal infectious disease diagnostics Market Product key takeaways (USD Million)
  • Fig. 20 U.S. Companion animal infectious disease diagnostics Market: product movement analysis
  • Fig. 21 Consumables, Reagents & Kits market, 2021 - 2033 (USD Million)
  • Fig. 22 Equipment & Instruments market, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Companion animal infectious disease diagnostics Market Technology key takeaways (USD Million)
  • Fig. 24 U.S. Companion animal infectious disease diagnostics Market: Technology movement analysis
  • Fig. 25 Immunodiagnostics market, 2021 - 2033 (USD Million)
  • Fig. 26 Lateral Flow Assays market, 2021 - 2033 (USD Million)
  • Fig. 27 ELISA Test market, 2021 - 2033 (USD Million)
  • Fig. 28 Others market, 2021 - 2033 (USD Million)
  • Fig. 29 Molecular Diagnostic market, 2021 - 2033 (USD Million)
  • Fig. 30 Polymerase Chain Reaction (PCR) Tests market, 2021 - 2033 (USD Million)
  • Fig. 31 Microarrays market, 2021 - 2033 (USD Million)
  • Fig. 32 Others market, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Companion animal infectious disease diagnostics Market Infection type key takeaways (USD Million)
  • Fig. 34 U.S. Companion animal infectious disease diagnostics Market: Infection Type movement analysis
  • Fig. 35 Bacterial market, 2021 - 2033 (USD Million)
  • Fig. 36 Viral market, 2021 - 2033 (USD Million)
  • Fig. 37 Parasitic market, 2021 - 2033 (USD Million)
  • Fig. 38 Others market, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. Companion animal infectious disease diagnostics Market by End Use key takeaways (USD Million)
  • Fig. 40 U.S. Companion animal infectious disease diagnostics Market: by End Use movement analysis
  • Fig. 41 Veterinary Reference Laboratories market, 2021 - 2033 (USD Million)
  • Fig. 42 Veterinary Hospitals and Clinics market, 2021 - 2033 (USD Million)
  • Fig. 43 Others market, 2021 - 2033 (USD Million)
  • Fig. 44 Market participant categorization